Back to top

moving-average-crossover: Archive

Zacks Equity Research

Gen Digital (GEN) Soars 5.6%: Is Further Upside Left in the Stock?

Gen Digital (GEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

GENNegative Net Change COHRNegative Net Change

Zacks Equity Research

Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?

Precigen (PGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

PGENNegative Net Change NRIXPositive Net Change

Zacks Equity Research

CBOE (CBOE) Surges 3.4%: Is This an Indication of Further Gains?

CBOE (CBOE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

CBOEPositive Net Change SPGINegative Net Change

Zacks Equity Research

VEON (VEON) Soars 6.6%: Is Further Upside Left in the Stock?

VEON (VEON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

VEONPositive Net Change BCEPositive Net Change

Zacks Equity Research

Applied Materials (AMAT) Recently Broke Out Above the 50-Day Moving Average

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?

AMATNegative Net Change

Zacks Equity Research

Altisource Portfolio (ASPS) Surges 15.3%: Is This an Indication of Further Gains?

Altisource Portfolio (ASPS) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock doesn't suggest further strength down the road.

ASPSNegative Net Change RCPositive Net Change

Zacks Equity Research

Iovance Biotherapeutics (IOVA) Surges 31.5%: Is This an Indication of Further Gains?

Iovance Biotherapeutics (IOVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

IOVANegative Net Change JANXPositive Net Change

Zacks Equity Research

Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?

Teleflex (TFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

TFXNegative Net Change DCTHNegative Net Change

Zacks Equity Research

Akamai Technologies (AKAM) Soars 3.2%: Is Further Upside Left in the Stock?

Akamai Technologies (AKAM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

AKAMNegative Net Change ATHMNegative Net Change

Zacks Equity Research

HireQuest (HQI) Stock Jumps 6.9%: Will It Continue to Soar?

HireQuest (HQI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

HQINegative Net Change RHIPositive Net Change